Kannan Natarajan

12PUBLICATIONS
27CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 25, 2026
Antibody Blockade of Ly49/MHC-I interactions enhances Innate and Adaptive Immunity Against Cancer Metastasis.

|Feb 02, 2026
Structural mechanism of anti-MHC-I antibody blocking of inhibitory NK cell receptors in tumor immunity.

Jiansheng Jiang, Abir K Panda, Kannan Natarajan

|Dec 03, 2025
Structural mechanism of anti-MHC-I antibody blocking of inhibitory NK cell receptors in tumor immunity.

Jiansheng Jiang, Abir K Panda, Kannan Natarajan

|Oct 01, 2025
Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity.

Abir K Panda, Kannan Natarajan, Surajit Sinha

|Apr 24, 2024
Chaperone-mediated MHC-I peptide exchange in antigen presentation.

Jiansheng Jiang, Kannan Natarajan, David H Margulies

|Mar 08, 2024
Experimental Structures of Antibody/MHC-I Complexes Reveal Details of Epitopes Overlooked by Computational Prediction.

Lisa F Boyd, Jiansheng Jiang, Javeed Ahmad

Pageof 2

Frequent Collaborators

12 joint publications

David Margulies

11 joint publications

Jiansheng Jiang

6 joint publications

Lisa F Boyd

4 joint publications

Ethan M Shevach